Latest

Clinical trial register · Ireland

Clinical Trials in Cork

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 616 matching records held by the registry are in this view. Synced 17 Sep 2026, 08:22 UTC

616

Studies in scope

all four open statuses

324

Recruiting now

open to new participants

181

Lead sponsors

across recruiting studies

Irish site locations

across all listed studies

Phase mix of the 324 recruiting studies

Phase 3 99 Not applicable 79 Observational 76 Phase 2 30 Phase 1/2 20 Other 20

Narrow the register Reset

Search within results

Matches title, registry number, sponsor, intervention and condition.

Recruitment status

Phase

Lead sponsor

Site location

All 3 locations

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

Irish sites

Start

Recruiting

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

NCT07227402 Renal Cell Carcinoma

Merck Sharp & Dohme LLC

Phase 3

904

Cork, Dublin

2025-11-26

Active, closed

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

NCT02811861 Renal Cell Carcinoma

Eisai Inc.

Phase 3

1,069

Cork, Dublin, Galway

2016-10-13

Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site, filtered. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 17 September 2026. https://priyalifescience.com/clinical-trials-ireland/city/cork

Query this register directly

GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.